Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer
Background: Metastatic hormone-sensitive prostate cancer (mHSPC) requires accessible biomarkers for better prognostication. This study investigated the prognostic value of the alkaline phosphatase-to-albumin ratio (APAR) in mHSPC survival risk stratification.Methods: We retrospectively analyzed 128 mHSPC patients. A cut-off of 2.92 for APAR was determined via ROC analysis. Overall survival (OS) was assessed using Kaplan–Meier methods and multivariable Cox regression adjusting for standard prognostic factors, including tumor volume and Gleason score.Results: Patients with APAR ≥2.92 had significantly shorter OS compared to those with APAR
Authors
- Ozge Yetginoglu (ORCID: https://orcid.org/0000-0002-0684-8710)
- Hüseyin Salih Semiz (ORCID: https://orcid.org/0000-0002-7083-8517)
- Faruk Recep Özalp (ORCID: https://orcid.org/0000-0002-2863-3243)
- Ahmet Melih Arslan (ORCID: https://orcid.org/0000-0002-6126-4611)
Publication Details
- Journal
- Journal of Basic and Clinical Health Sciences
- Published
- 2026-05-31
- DOI
- https://doi.org/10.30621/jbachs.1834209
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00